AMARIN CORP PLC\UK

AMRN ·Healthcare, Drug Manufacturers - General
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $134.7M $121.0M $199.3M $217.7M $219.5M $187.0M $644.6M $249.2M
Accounts Receivable $126.8M $122.3M $133.6M $131.0M $163.7M $154.6M $116.4M $66.5M
Inventory $195.9M $166.0M $258.6M $228.7M $234.7M $188.9M $76.8M $57.8M
Total Current Assets $649.9M $595.4M $725.0M $689.1M $878.7M $879.2M $855.0M $378.0M
Property, Plant & Equipment $12.0K $16.0K $114.0K $874.0K $1.4M $2.0M $2.4M $63.0K
Goodwill
Intangible Assets (Excl. Goodwill) $13.4M $16.4M $19.3M $21.8M $23.5M $13.8M $15.3M $7.5M
Total Assets $670.8M $685.3M $831.7M $886.2M $1.07B $966.0M $882.2M $385.7M
Liabilities
Accounts Payable $45.4M $40.4M $52.8M $64.6M $114.9M $105.9M $50.0M $37.6M
Total Current Liabilities $194.5M $179.9M $259.3M $259.5M $370.7M $307.4M $242.2M $157.3M
Long-Term Debt $49.7M $46.1M
Total Liabilities $211.5M $199.2M $279.6M $290.8M $401.0M $338.5M $273.9M $233.4M
Stockholders' Equity
Retained Earnings $-1.71B $-1.67B $-1.59B $-1.53B $-1.42B $-1.43B $-1.41B $-1.39B
Total Stockholders' Equity $459.3M $486.2M $552.1M $595.3M $667.1M $627.5M $608.3M $152.3M
← Newer Page 1 of 3 Older →